Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures hormones steroid products such as asabiraterone acetate, exemestane, rocuronium bromide etc
Symbiotec Pharmalab Private Limited, is an unlisted private company incorporated on 20 September, 2002. It is classified as a private limited company and is located in Indore, Madhya Pradesh. It's authorized share capital is INR 12.00 cr and the total paid-up capital is INR 10.94 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
19.52%
79.03%
13.13%
-51.79%
19.46%
3.68
7.02
16.76
15.06
9.21
-0.09
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(3)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SBICap Trustee Company Limited
No. of Loans: 1
Total Amount : 386.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 289.0 cr
Axis Bank Limited
No. of Loans: 1
Total Amount : 2.0 cr
Yes Bank Limited
No. of Loans: 1
Total Amount : 0.5 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Anil Kumar Satwani
Shareholder
|
00041531 | 22 years |
| Nominee Director | Shankar Gopalakrishnan . | 00392337 | 6 years |
| Director | Buggana Hariharnath | 00695002 | 0 years |
| Nominee Director | Rohit Brijmohan Mantri | 07435803 | 6 years |
| CFO | Raghavender Ramachandran | <HIDDEN> | 3 years |
| CS | Salil Jain | <HIDDEN> | 7 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SPL LIFESCIENCE INDIA PRIVATE LIMITED |
Under Process of Striking Off
|
6.0 L | 1 | Madhya Pradesh |
| KNOVEA PHARMACEUTICAL PRIVATE LIMITED |
Active
|
1.0 Cr | 3 | Madhya Pradesh |
| SYMBIOTEC STEROIDS PRIVATE LIMITED |
Converted to LLP
|
33.3 L | 1 | Madhya Pradesh |
| SYMBIOTEC LIFESCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Madhya Pradesh |
| AAKARSHAN REALINFRA LLP |
Active
|
1.0 L | 1 | Madhya Pradesh |
| SATWANI HOLDINGS LLP |
Active
|
1.6 Cr | 1 | Madhya Pradesh |
| AZADU COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Pradesh |
| LOGISTOS REAL ESTATE LLP |
Active
|
25,000.0 | 1 | Pradesh |
| CYNOR COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Pradesh |
| RUGGO COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Pradesh |
| REALTOHOUSE COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Pradesh |
| JUMPFIELD COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Pradesh |
| NIOLLO COMMERCIALS LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| BUILDWELLS INDUSTRIALS LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| GOROLY INDUSTRIALS LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| PROPEZY REAL ESTATE LLP |
Active
|
25,000.0 | 1 | Pradesh |
| FASTORQ INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| READY TO GO INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| MOVECLEVER INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| REAL INNOVATORS INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| STAY VIGOROUS INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| ELEVATED INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| UPTURN INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| SEA TO SKY INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| BUILT WITH ELEGANCE INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| RARE ICON INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| DIVINE DELIGHT INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| FLAME BRIGHT INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| TRUE LEGACY INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| MOVEWELL INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| SIGHTHIGH INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| TRUEWAVE INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| TOPDYNASTY INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| GROTRACK INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| CREATIVE HUES INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| TRUEBOLT INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| SOLIDRAY INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| GREATXPECTATIONS INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| FUZICO INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| SAGE START INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Madhya Pradesh |
| STORMFLEET INDUSTRIES LLP |
Active
|
25,000.0 | 1 | Pradesh |
| ARINNA LIFESCIENCES LIMITED |
Active
|
13.1 Cr | 2 | Gujarat |
| AURIGENE ONCOLOGY LIMITED |
Active
|
187.6 Cr | 1 | Karnataka |
| STRIDES CONSUMER PRIVATE LIMITED |
Active
|
72.7 Cr | 1 | Maharashtra |
| TOTAL PROSTHETICS & ORTHOTICS INDIA PRIVATE LIMITED |
Under Liquidation
|
86.3 Cr | 1 | Haryana |
| MAIVA PHARMA PRIVATE LIMITED |
Active
|
24.7 Cr | 1 | Karnataka |
| INVASCENT ADVISORY SERVICES INDIA LLP |
Active
|
10.0 L | 1 | Telangana |
| ACCUMAX LAB DEVICES PRIVATE LIMITED |
Active
|
11.1 Cr | 1 | Gujarat |
| BIGTEC PRIVATE LIMITED |
Active
|
4.5 Cr | 1 | Karnataka |
| INDIA REALTY EXCELLENCE FUND II LLP |
Active
|
489.3 Cr | 1 | Delhi |
| MOLBIO DIAGNOSTICS PRIVATE LIMITED |
Active
|
2.3 Cr | 1 | Goa |
| GANESH CONSUMER PRODUCTS LIMITED |
Active
|
36.4 Cr | 1 | West Bengal |
| PATHKIND DIAGNOSTICS PRIVATE LIMITED |
Active
|
15.8 Cr | 1 | Delhi |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| NaviSci. Pte. Ltd | Singapore | - | - |
| SPL LIFESCIENCE INDIA PRIVATE LIMITED | Madhya Pradesh | 2015 | ₹ 6.0 L |
| NaviSci Pte. Ltd | Singapore | - | - |
The incorporation date of SYMBIOTEC PHARMALAB PRIVATE LIMITED is 20 September, 2002
The authorized share capital of SYMBIOTEC PHARMALAB PRIVATE LIMITED is INR ₹ 12.0 Cr.
The paid-up capital of SYMBIOTEC PHARMALAB PRIVATE LIMITED is INR ₹ 10.9 Cr.
The registered address of SYMBIOTEC PHARMALAB PRIVATE LIMITED is 385/2, PIGDAMBER NEAR MASHAL HOTEL, RAU INDORE Madhya Pradesh - 453446
The CIN number of SYMBIOTEC PHARMALAB PRIVATE LIMITED is U24232MP2002PTC015293.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
